Provided by Tiger Fintech (Singapore) Pte. Ltd.

Revolution Medicines, Inc.

39.14
-0.6300-1.58%
Post-market: 39.140.00000.00%16:31 EDT
Volume:1.55M
Turnover:61.23M
Market Cap:7.29B
PE:-9.74
High:40.57
Open:39.50
Low:39.14
Close:39.77
Loading ...

S&P 500 Futures Rise In Premarket Trading; Trump Media & Tech, Stellantis Lead

Dow Jones
·
27 May

Revolution Medicines Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
15 May

Revolution Medicines Doses First Patient in Late-Stage Trial Evaluating Daraxonrasib to Treat Lung Cancer

MT Newswires Live
·
14 May

Revolution Medicines Announces First Patient Dosed in Phase 3 Clinical Trial Evaluating Daraxonrasib in Previously Treated Patients With Ras Mutant Non-Small Cell Lung Cancer

THOMSON REUTERS
·
14 May

Revolution Medicines Is Maintained at Buy by Guggenheim

Dow Jones
·
08 May

Stock Track | Revolution Medicines (RVMD) Soars 8.26% as Analysts Maintain Bullish Stance Despite Mixed Price Targets

Stock Track
·
08 May

Revolution Medicines Price Target Maintained With a $57.00/Share by Needham

Dow Jones
·
08 May

Stock Track | Revolution Medicines (RVMD) Surges 5.74% Pre-market on Positive Analyst Sentiment Despite Price Target Cut

Stock Track
·
08 May

Stock Track | Revolution Medicines (RVMD) Surges 5.74% in Pre-market Following Analyst Buy Ratings

Stock Track
·
08 May

Buy Recommendation for Revolution Medicines: Promising RAS(ON) Platform and Strong Financial Position

TIPRANKS
·
08 May

Barclays Sticks to Its Buy Rating for Revolution Medicines (RVMD)

TIPRANKS
·
08 May

Revolution Medicines Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Revolution Medicines Q1 Net Loss Widens

MT Newswires Live
·
08 May

Stock Track | Revolution Medicines Soars 9.16% After-Hours on Q1 Results and Extended Cash Runway

Stock Track
·
08 May

Stock Track | Revolution Medicines Soars 9.16% After-Hours on Q1 Results and Strong Cash Position

Stock Track
·
08 May

Earnings Flash (RVMD) Revolution Medicines Q1 Loss $1.13 Vs. FactSet Est. Loss $1.10

MT Newswires Live
·
08 May

Revolution Medicines Q1 EPS $(1.13) Misses $(1.08) Estimate

Benzinga
·
08 May

BRIEF-Revolution Medicines Q1 EPS USD -1.13

Reuters
·
08 May

Revolution Medicines Reports First Quarter 2025 Financial Results and Update on Corporate Progress

THOMSON REUTERS
·
08 May

Revolution Medicines Q1 EPS USD -1.13

THOMSON REUTERS
·
08 May